• Blog
  • Extracorporeal CO2 Removal Market Report

    Extracorporeal CO2 Removal Market Report

    Extracorporeal CO2 Removal Market Report
    Report code - SR1782 Delivery - 2 Weeks
    Extracorporeal CO2 Removal Market Size, Share & Forecast Analysis (2021-2026)
    See more...

    Market Insights

    The Extracorporeal CO2 Removal Market is estimated to grow from USD 82.6 million in 2020 to USD 113.4 million by 2026 at a healthy CAGR of 5.5% during the forecast period.

    Extracorporeal CO2 Removal Market- Research Scope

    Base Year of Study

    2020

    Trend Period

    2015-2019

    Forecast Period

    2021-2026

    Market Size in 2020

    US$ 82.6 million

    Market Size in 2026

    US$ 113.4 million

    Market Growth (2021-2026)

    5.5% CAGR

     

    Figure: Extracorporeal CO2 Removal Market Size, 2020-2026 (USD Million)

    Wish to get a free sample? Register Here

    What is Extracorporeal CO2 Removal?

    Extracorporeal CO2 Removal (ECCO2R) devices successfully remove carbon dioxide but do not offer significant oxygenation, unlike extracorporeal membrane oxygenation (ECMO) devices. ECCO2R devices exhibit certain distinctive features such as, low blood flow ranging from 350-1000 ml/min, which makes them less complex than ECMO devices. These devices provide infrequent adverse reactions against ECMO and smaller vascular access.

    Covid-19 Impact Analysis

    The COVID-19 pandemic has positively influenced the extracorporeal CO2 removal industry. Also, infections caused by coronavirus (SARS-CoV-2) substantially affected the respiratory tracts, and the suspected patients required mechanical ventilation and developed severe hypoxemia. The usage of extracorporeal CO2 removal devices has surged since the start of COVID-19.

    Key Players

    Key players operating in the global Extracorporeal CO2 Removal Market are-

    • Medtronic (Ireland)
    • Getinge AB (Sweden)
    • Xenios AG (Germany)
    • Alung Technologies (US)
    • ESTOR SpA (Italy)
    • Medica SpA (Italy)
    • Aferectica Srl (Italy)

    Market Dynamics

    The Extracorporeal CO2 Removal market is majorly driven by surging incidences of Chronic Obstructive Pulmonary Disease (COPD) and Acute Respiratory Distress Syndrome (ARDS), which has resulted in the introduction of novel products for stimulating blood flow and efficient gas exchange. Moreover, surging number of regulatory product approvals for different extracorporeal removal devices amid the pandemic further helped various product manufacturers to increase their product sales, thereby augmenting the market growth.

    Segments Analysis

    Product Trends

    Based on product, the extracorporeal CO2 removal market has been classified into extracorporeal CO2 machines, disposables, and others. The extracorporeal CO2 machines segment accounted for the largest market of almost 53% in 2020. Extracorporeal CO2 removal devices have become simpler and require fewer personnel as well as logistic requirements, thus resulting in an increased preference among patients, thus boosting the segment growth.

    Regional Trends

    By region, the North America Extracorporeal CO2 Removal market accounted the highest share of around 35% in 2020 and is expected to grow at a robust CAGR during the review period. The Extracorporeal CO2 Removal market growth is mainly attributed to changing lifestyle of the people, high product adoption presence of key product manufacturers, rising incidence of lifestyle-associated factors, and rising respiratory diseases augments the regional market growth during the forecast timeline.

    The Asia Pacific Extracorporeal CO2 Removal market is expected to grow at the healthy CAGR during the review period due to growing awareness regarding acute respiratory failure, rising government healthcare expenditure in developing economies, and presence of a large patient pool, and increasing disposable income, further bolsters the regional market growth.

    Critical Questions Answered in the Report

    This market research report provides in-depth information on trends, dynamics, revenue opportunities, competitive landscape, and recent developments in the global Extracorporeal CO2 Removal market. The historic years considered for the study are 2016-2019, base year is 2020, estimated year is 2021, and forecast period is 2022-2026. Following are the critical questions answered in the report.

    • What are the key trends in the global Extracorporeal CO2 Removal market?
    • How the market (and its various sub-segments) has grown in the last five years and what would be the growth rate in next five years?
    • What is the impact of COVID-19 on global Extracorporeal CO2 Removal market?
    • What are the key strategies adopted by the major vendors to lead in the global Extracorporeal CO2 Removal market?
    • What is the market share of the top vendors?

    Target Audience

    The target audience of Extracorporeal CO2 Removal Market includes-

    • Extracorporeal CO2 Removal Vendors
    • Extracorporeal CO2 Removal Manufacturers
    • Extracorporeal CO2 Removal Distributors
    • Organizations
    • Government Bodies.

    Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at sales@stratviewresearch.com.

    Frequently Asked Questions (FAQs)

    The Global Extracorporeal CO2 Removal Market is estimated to grow from USD 82.6 million in 2020 to USD 113.4 million by 2026 at a healthy CAGR of 5.5% during the forecast period.

    Key players operating in the global Extracorporeal CO2 Removal Market are- Medtronic (Ireland), Getinge AB (Sweden), Xenios AG (Germany), Alung Technologies (US), ESTOR SpA (Italy), Medica SpA (Italy), Aferectica Srl (Italy).

    The Extracorporeal CO2 Removal market is majorly driven by surging incidences of Chronic Obstructive Pulmonary Disease (COPD) and Acute Respiratory Distress Syndrome (ARDS).

    North America Extracorporeal CO2 Removal market accounted the highest share of around 35% in 2020 and is expected to grow at a robust CAGR during the review period.

    The target audience of Extracorporeal CO2 Removal Market includes- Extracorporeal CO2 Removal Vendors, Extracorporeal CO2 Removal Manufacturers, Extracorporeal CO2 Removal Distributors, Organizations, Government Bodies.